Lineage Cell Therapeutics (LCTX) Research & Development (2010 - 2026)
Lineage Cell Therapeutics' Research & Development came in at $4.77 million for Q2 2026, up 53.7% from $3.11 million a year earlier and up 12.8% from the prior quarter.
Powered by 
Analysis
Lineage Cell Therapeutics (LCTX) Research & Development (2010 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Lineage Cell Therapeutics reported Research & Development of $20.52 million, up 60.1% year-over-year; for FY2025, it was $17.73 million, up 42.2% from FY2024.
- Research & Development carries a five-year compound annual growth rate of 7.6% (FY2020 to FY2025).
- Going back by year, Research & Development was $12.47 million in FY2024 (-20.6%), $15.71 million in FY2023 (+12.3%), $13.99 million in FY2022 (-58.8%) and $33.91 million in FY2021 (+175.3%).
- The five-year range for quarterly Research & Development is $2.81 million (Q3 2021) to $24.78 million (Q4 2021).
- Year-over-year, Research & Development has increased for six consecutive quarters, with growth averaging 27.2% over the last eight quarters.
- The fastest year-over-year change in Research & Development over five years came in Q4 2021 (growth of 850.4%), and the weakest in Q4 2022 (a decline of 83.4%).
- Business Quant data shows LCTX's Research & Development at $4.23 million (Q1 2026), $8.24 million (Q4 2025) and $3.27 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 3.65 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 2.34 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 9.74 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | -2.85 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -4.05 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 1.87 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 1.76 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 2.81 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 993.80 Mn |
| 10 | Lineage Cell Therapeutics | 245.32 Mn | 43.73 Mn | - | 4.77 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 4.77 Mn |
| Mar 31, 2026 | 4.23 Mn |
| Dec 31, 2025 | 8.24 Mn |
| Sep 30, 2025 | 3.27 Mn |
| Jun 30, 2025 | 3.11 Mn |
| Mar 31, 2025 | 3.11 Mn |
| Dec 31, 2024 | 3.42 Mn |
| Sep 30, 2024 | 3.17 Mn |
| Jun 30, 2024 | 2.87 Mn |
| Mar 31, 2024 | 3.01 Mn |
| Dec 31, 2023 | 3.91 Mn |
| Sep 30, 2023 | 3.74 Mn |
| Jun 30, 2023 | 3.87 Mn |
| Mar 31, 2023 | 4.19 Mn |
| Dec 31, 2022 | 4.10 Mn |
| Sep 30, 2022 | 3.59 Mn |
| Jun 30, 2022 | 3.30 Mn |
| Mar 31, 2022 | 2.99 Mn |
| Dec 31, 2021 | 24.78 Mn |
| Sep 30, 2021 | 2.81 Mn |
API Access
Lineage Cell Therapeutics Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=LCTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "LCTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=LCTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();